1
HER2-directed Biosimilar in Breast Cancer: Real World ePRO
Condition(s):HER2-positive Breast Cancer; Biosimilar; Patient Reported OutcomeLast Updated:October 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):HER2-positive Breast Cancer; Biosimilar; Patient Reported OutcomeLast Updated:October 4, 2022Recruiting
Condition(s):Telemedicine; eHealthLast Updated:February 1, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.